Literature DB >> 10398580

[Secretory carcinoma of the breast. Report of a case in a 9-year-old boy].

A Chevallier1, C Boissy, A Rampal, C Soller, C Turc-Carel, A Thyss, J F Michiels.   

Abstract

The authors report a child male case of secretory carcinoma of the breast, associated with a abnormal tumoral karyotype (monosomy 22). The diagnosis was made by histopathological examination. This breast carcinoma is characterized by an abundant intra and extracellulary secretory material, which present a reactivity with antimilk proteins antibodies and includes spherical dense bodies, identified by ultrastructural study. The prognosis is not bad, whatever the age of the patient, particularly for the children and young women, displaying an locoregional aggressivity. The signification of a monosomy 22 in secretory carcinoma is unknown.

Entities:  

Mesh:

Year:  1999        PMID: 10398580

Source DB:  PubMed          Journal:  Clin Exp Pathol        ISSN: 1292-7953


  5 in total

1.  A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.

Authors:  Jinhua Ding; Li Jiang; Yongli Gan; Weizhu Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Secretory breast carcinoma with metastatic sentinel lymph node.

Authors:  Salvatore Vieni; Daniela Cabibi; Calogero Cipolla; Salvatore Fricano; Giuseppa Graceffa; Mario Adelfio Latteri
Journal:  World J Surg Oncol       Date:  2006-12-06       Impact factor: 2.754

3.  Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature.

Authors:  C Arce; D Cortes-Padilla; D G Huntsman; M A Miller; A Dueñnas-Gonzalez; A Alvarado; V Pérez; D Gallardo-Rincón; F Lara-Medina
Journal:  World J Surg Oncol       Date:  2005-06-17       Impact factor: 2.754

4.  Secretory carcinoma of male breast: case report and review of the literature.

Authors:  S Gabal; S Talaat
Journal:  Int J Breast Cancer       Date:  2011-02-06

5.  Secretory carcinoma of breast in a 17-year-old male.

Authors:  Alfie J Kavalakat; Ramani K Covilakam; Terence B Culas
Journal:  World J Surg Oncol       Date:  2004-06-02       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.